Olivier Bohuon - Smith Nephew Insider

Smith Nephew plc -- USA Stock  

USD 17.71  0.00  0.00%

CEO, Director, Chairman of Disclosures Committee, Chairman of Executive Risk Committee and Member of Nomination and Governance Committee

Mr. Olivier Bohuon is Chief Executive Officer, Executive Director of Smith and Nephew PLC. Olivier holds a doctorate in Pharmacy from the University of Paris and an MBA from HEC, Paris. He started his career in Morocco with Roussel Uclaf S.A. and then, with the same company, held a number of positions in the Middle East with increasing levels of responsibility. He joined Abbott in Chicago as head of their antiinfective franchise with Abbott International before becoming Pharmaceutical General Manager in Spain. He subsequently joined GlaxoSmithKline, rising to Senior Vice President Director for European Commercial Operations. He then rejoined Abbott as President for Europe, became President of Abbott International, and then President of their Pharmaceutical Division. He joined Smith Nephew from Pierre Fabre, where he was Chief Executive. Olivier has extensive international healthcare leadership experience within a number of significant pharmaceutical and healthcare companies. His global experience provides the skillset required to innovate a FTSE 100 company with a deep heritage and provide inspiring leadership. He is a NonExecutive Director of Virbac Group and Shire plc, where he is also a member of the Remuneration Committee.
Age: 57  Chairman Since 2011  MBA    
44 20 7401 7646  http://www.smith-nephew.com

Management Efficiency

The company has return on total asset (ROA) of 7.78 % which means that it generated profit of $7.78 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 21.29 % meaning that it generated $21.29 on every $100 dollars invested by stockholders.
The company has accumulated 1.67 B in total debt with debt to equity ratio (D/E) of 39.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Smith Nephew plc has Current Ratio of 2.14 suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due.

Similar Executives

Entity Summary

Smith & Nephew plc develops, manufactures, markets, and sells medical technology solutions and services worldwide. Smith Nephew plc (SNNUF) is traded on OTC Market in USA. It is located in London, WCN LA and employs 15,000 people.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Smith Nephew plc to your portfolio

Top Management

Smith Nephew plc Leadership Team
Michael Friedman, Director, Ph.D
Diogo MoreiraRato, President
Erik Engstrom, Director, MBA
Matthew Stober, President
Marc Owen, Director
Rodrigo Bianchi, President
Brian Larcombe, Director
Elga Lohler, Executive
Gunthorp Oie, Executive
Helen Maye, Executive
Vinita Bali, Director, MBA
R Howe, President
Olivier Bohuon, Chairman, MBA
Graham Baker, Director
Roberto Quarta, Chairman
Cyrille Petit, Executive
Julie Brown, Director, MBA
Glenn Warner, President
Robin Freestone, Director
Virginia Bottomley, Director
Angie Risley, Director
Vasant Padmanabhan, President, Ph.D
Michael Frazzette, President
Joseph Papa, Director, MBA
Ingeborg Oie, VP
Susan Swabey, Executive
Gordon Howe, President
John Campo, Executive
Brad Cannon, President
Ian Barlow, Director

Stock Performance

Smith Nephew Performance Indicators